By Keith L. Carson
Volume 11, Issue 4 (Winter 2012/2013)
The pace of M&As hasn’t slowed. It has become next to impossible to keep up with biotech company names, and some organizations can’t tell you what they are supposed to be called. I’m not exaggerating when I say that no one within some of these large organizations can tell you what name you should show in your database, what distinguishes their divisions, or what logo you should show as you give them credit for sponsoring an event or placing an ad…
Citation: Carson KL. From the Editor-in-Chief: What is Your Name Again? BioProcess J, 2012; 11(4): 3. https://doi.org/10.12665/J114.Carson
Posted online July 27, 2026